Models
/
Commercial Performance

Create Targeted Strategies and Track Results.

Precision medicines need precision insights. Gain the insights you need to compete differently and fill the gaps left by traditional data analysis. ClosedLoop’s predictive analytics for Life Science commercial teams can deliver precision, speed, and productivity and help you optimize your go-to-market strategy and maximize commercial performance.

‍

Get a Demo
Download Case Study
Well care image

Learn How

Precision medicines need precision insights. Gain the insights you need to compete differently and fill the gaps left by traditional data analysis. ClosedLoop’s predictive analytics for Life Science commercial teams can deliver precision, speed, and productivity.

Automatically ingest data from dozens of health data sources including...

No items found.
nodes
Closedloop icon with a line

ClosedLoop generates explainable predictions using

thousands of auto-generated, clinically relevant contributing factors

No items found.

Launch Planning

Leverage AI to power your launch, refine your market, and kickstart commercial performance.

  • Understand market size, key patient cohorts, and distinct provider segments
  • Use AI-enriched profiles to power marketing strategies, increase precision
  • Sub-segment patients with fine-tuned inclusion and exclusion criteria
  • Prioritize and rank providers using patient profiles and therapy-specific factors


Targeted Content 

‍Create targeted content based on the specific needs of key sub-populations and patient cohorts.

  • Identify key sub-populations with the greatest unmet needs 
  • Refine messaging with insights into disease severity, predicted outcomes, and health disparities
  • Increase ROI with precise prioritization of patient segments and provider targets 


Performance Tracking

‍Keep your finger on the pulse of your product and its impact.

  • Track performance and uptake in precision cohorts 
  • Monitor high-priority providers and adjust tailored messaging.
  • Measure real world outcomes and identify differential impacts in precision cohorts


New Opportunity Analysis

‍Business development and commercial teams need precise answers to gauge the value of
potential partnership deals and explore new market opportunities.

  • Make stronger assumptions about future uptake and pinpoint relevant patients (versus
    simply sizing based on conditions)
  • Refine pricing assumptions with data that reflects precision cohorts where you have differential impacts
  • Estimate the future cost of sales with analytics of providers and treatment patterns

‍

expand_more
Citations & Footnotes

ClosedLoop is an exciting and important partner in our strategy to develop timely predictive insights through operationalized AI solutions that will drive member engagement and better health outcomes.

Pat Wang
President & CEO, Healthfirst

Our partnership with ClosedLoop adds the depth of AI to more accurately identify those patients who are most likely to benefit from our primary care interventions as well to evaluate these interventions and make more relevant and timely modifications to improve their effectiveness.

David Klebonis
Chief Operating Officer, PBACO
Cheryl

We are extremely impressed with the predictive modeling capabilities the ClosedLoop platform has delivered. The ClosedLoop team has exceeded all defined goals and benchmarks set to date and we anticipate a substantial return on our investment as these predictions are operationally deployed.

Cheryl Lulias
President & Executive Director, MHN

We’re able to store and operationalize analytics directly from ClosedLoop. That’s driving real value—it’s accelerated the implementation of key insights into clinical workflows and it allows us to more easily account for all of the different factors that influence intervention decisions.

Christer Johnson
Chief Analytics Officer, Healthfirst

At SWHR, our patient-centered network is committed to innovative care models that are value-based, high-quality, and data-driven. Because of our partnership with ClosedLoop, we’re better able to identify and act on the most impactful opportunities for our physician partners to improve patient results and reduce unnecessary costs.

Dr. Jason Fish
Chief Medical Officer & SVP, Southwestern Health Resources

We compared the ClosedLoop predicted spend to the spend predicted by a leading rules-based risk prediction engine and found that 75% of the time ClosedLoop was closer, and in most cases significantly closer, to the actual spend.

Phillip Bruns
Chief Technology Officer, CareATC

Learn What ClosedLoop Can Do for Your Organization

The industry’s best collection of customizable predictive models for common healthcare use cases.
‍

Talk To An Expert